SCHEMBL10001600

SCHEMBL10001600

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cn5ccccc5c4-c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.48
ALDH1A1 P00352 10/20 0.44
KDM4E B2RXH2 8/20 0.44
HPGD P15428 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
GAA P10253 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A3 P47895 5/20 0.40
ALDH1A2 O94788 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1435638 0.87 HRH3 (0.53) HRH3ALDH1A1KDM4EHPGDMEN1
Iodide SCHEMBL10843763 0.85 HRH3 (0.52) HRH3ALDH1A1KDM4EHPGDMEN1
SCHEMBL6636591 0.81 HRH3 (0.50) HRH3ALDH1A1KDM4EHPGDMEN1
SCHEMBL9888862 0.78 KDM4E (0.47) HRH3ALDH1A1KDM4EHPGDMEN1
SCHEMBL6641997 0.77 KDM4E (0.56) HRH3ALDH1A1KDM4EHPGDMEN1
SCHEMBL9888857 0.76 KDM4E (0.49) HRH3ALDH1A1KDM4EHPGDMEN1
SCHEMBL20060287 0.76 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL22079668 0.76 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL15714522 0.76 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL22079936 0.75 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673460-B2 Heterocyclic derivative and organic light emitting device using same LG CHEM, LTD. (KR) 2014-03-18 US disclosed
US-8673460-B2 Heterocyclic derivative and organic light emitting device using same LG CHEM, LTD. (KR) 2014-03-18 US disclosed
US-20120161612-A1 NEW HETEROCYCLIC DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2012-06-28 US disclosed
US-20120161612-A1 NEW HETEROCYCLIC DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161612-A1 NEW HETEROCYCLIC DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME PPOX, CYBA, NQO1 HRH3 4229/4885ALDH1A1 144/4885KDM4E 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.